Joni Abramczyk
Nurse Practitioner · Dayton, OHNPI 1003365198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,412 and has fallen 61.8% since, to $540 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$954
- AbbVie$879
- Collegium Pharmaceutical, Inc.$864
- Medtronic$420
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$223
- Pfizer$202
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,187100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $954 |
| AbbVie(2 entities) | 55 | $879 |
| Collegium Pharmaceutical, Inc. | 72 | $864 |
| Medtronic | 11 | $420 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $223 |
| Pfizer | 13 | $202 |
| Vertos Medical, Inc. | 5 | $189 |
| GRT US Holding, Inc. | 9 | $170 |
| Biohaven Pharmaceuticals, Inc. | 8 | $130 |
| Nevro Corp. | 4 | $124 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $116 |
| Curonix LLC | 3 | $102 |
| Boston Scientific | 2 | $97 |
| Averitas Pharma Inc. | 4 | $88 |
| Vertex | 4 | $85 |
| Nalu Medical, Inc. | 1 | $61 |
| Stimwave Technologies Incorporated | 3 | $57 |
| IBSA Pharma Inc. | 4 | $57 |
| Lilly USA, LLC | 4 | $54 |
| Lundbeck LLC | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Amgen | 2 | $29 |
| Tersera Therapeutics LLC | 1 | $28 |
| Saluda Medical Americas, Inc. | 2 | $28 |
| MDD US Operations, LLC | 1 | $27 |
| Scilex Pharmaceuticals Inc. | 2 | $25 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Stryker | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$457
- INTELLIS ADAPTIVESTIM$120
How this compares
$5,187 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 45 | $31,710 |
| Xtampza ErOxycodone Myristate | 34 | $24,338 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 646 | $15,499 |
| UbrelvyUbrogepant | 11 | $13,598 |
| NucyntaTapentadol Hcl | 17 | $11,555 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 520 | $10,636 |
| Emgality PenGalcanezumab-Gnlm | 12 | $8,328 |
| Pregabalin | 179 | $5,798 |
| MovantikNaloxegol Oxalate | 14 | $5,537 |
| Buprenorphine | 22 | $5,247 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $4,502 |
| Gabapentin | 299 | $3,247 |
| Oxycodone Hcl | 42 | $3,163 |
| Morphine Sulfate ErMorphine Sulfate | 108 | $2,786 |
| Fentanyl | 14 | $1,801 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $864 | $35,89351 claims |
| AbbVieUbrelvy | $879 | $13,59811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Dayton
- Abby SipeDayton$47K
- Ann NieDayton$34K
- Jennifer PhillipsDayton$13K
- April LenzDayton$11K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.